Our CEO Kevin Hrusovsky is speaking on a panel during the forum, details below:

Who: Kevin Hrusovsky, CEO and Executive Chairman, Quanterix 

What: “Precision Cardiovascular Medicine: What is Different This Time”

Where: World Medical Innovation Forum, Boston Scientific Ballroom

When: Tuesday, May 2nd, 2:00 – 2:50 pm ET

Why: This session will explore how precision medicine is transforming the study and treatment of cardiovascular diseases. Specifically, the 50-minute panel, which will take the form of a moderated, open dialogue among five industry experts, will discuss the impact of combined phenotypic and genotypic characterization on optimizing response to therapeutics, and how new discoveries and technologies are changing trial design, improving outcomes, and redefining reimbursement. 

View the recording of the panel session here